58 related articles for article (PubMed ID: 7690534)
1. [A case of metastatic splenic tumor treated with intra-arterial immunochemotherapy to induce endogenous LAK cell].
Ogawara T; Sekikawa T; Kouno K; Matsumoto Y
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1446-9. PubMed ID: 7690534
[TBL] [Abstract][Full Text] [Related]
2. [Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors].
Akimoto M; Nishihira T; Hirakawa H; Abe M; Ohuchi N; Mori S; Kumagai K
Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):64-74. PubMed ID: 2014029
[TBL] [Abstract][Full Text] [Related]
3. [Infusion of LAK cells and anticancer drugs with a total implantable port to a patient with metastatic liver and spleen tumors].
Kimura H; Yamaguchi Y; Ebara M; Yosikawa M
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1996-2000. PubMed ID: 1877842
[TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent pelvic tumor of sigmoid colon cancer showing partial response to lipiodolization].
Shimoda K; Hazama S; Mitsunaga H; Uchiyama T; Oka M; Suzuki T
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1951-4. PubMed ID: 1652230
[TBL] [Abstract][Full Text] [Related]
5. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
[TBL] [Abstract][Full Text] [Related]
6. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of hepatic metastasis of colorectal cancer treated effectively by intrahepatic arterial infusion immunotherapy using OK-432, rIL-2, MMC and 5-FU].
Tomita F; Kurosaka Y; Matsushita M; Akiyama T; Kiriyama M; Hitoshi ; Kosaka T; Kita I; Takashima S
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2190-3. PubMed ID: 7944437
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H
Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
[TBL] [Abstract][Full Text] [Related]
11. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
Fujioka A; Sugitani M; Suzuki Z; Tokita J; Yorimitsu K; Sezai Y
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1958-61. PubMed ID: 1877838
[TBL] [Abstract][Full Text] [Related]
12. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
13. [Induction of anti-cancer cells and systemic immune response in hepatocellular carcinoma by OK-432].
Aramaki M; Nakashima K; Sasaki A; Shimoda K; Yoshida T; Kim YI; Kitano S; Kobayashi M
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2115-7. PubMed ID: 7944416
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients.
Logan TF; Gooding W; Kirkwood JM; Shadduck RK
Exp Hematol; 1996 Jan; 24(1):49-53. PubMed ID: 8536792
[TBL] [Abstract][Full Text] [Related]
15. [A case report: ovarian carcinoma IVth can become complete remission by immunochemotherapy].
Shimizu A; Hondoh T; Watanabe S; Moriyama S; Yoshida K; Miyakawa Z; Kimura T; Notake Y; Mitsuya T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2346-9. PubMed ID: 7944476
[TBL] [Abstract][Full Text] [Related]
16. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
17. [Locoregional adoptive immunotherapy using LAK cells and IL-2 against liver metastases from digestive tract cancer].
Ueda Y; Sonoyama T; Itoi H; Fujiwara H; Fuji N; Itoh T; Fujiki H; Yamashita T; Yoshimura T; Harada S; Okugawa K; Yamagishi H
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1962-5. PubMed ID: 11086454
[TBL] [Abstract][Full Text] [Related]
18. Solitary splenic metastasis from gastric cancer: report of a case.
Yamanouchi K; Ikematsu Y; Waki S; Kida H; Nishiwaki Y; Gotoh K; Ozawa T; Uchimura M
Surg Today; 2002; 32(12):1081-4. PubMed ID: 12541027
[TBL] [Abstract][Full Text] [Related]
19. [Adoptive immunotherapy in patients with multiple hepatic cancers using lymphokine activated killer cells (LAK) and interleukin-2].
Kanai T; Monden M; Takeda T; Gotoh M; Sakon M; Umeshita K; Hasuike Y; Sakita I; Nakano H; Yoshida T
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1457-60. PubMed ID: 8396896
[TBL] [Abstract][Full Text] [Related]
20. [Successful treatment of metastatic bone cancer from colon with combination treatment (radiation and 5-FU); a case report].
Nakanishi K; Ueno Y; Nakamura N; Yoshikawa H; Takeuchi T; Tanihata H; Masuda M; Terada M; Satoh M; Okamoto E
Gan To Kagaku Ryoho; 1999 Feb; 26(3):353-6. PubMed ID: 10065099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
